Conformationally defined 6-s-trans-retinoic acid analogs .3. Structure-activity relationships for nuclear receptor binding, transcriptional activity, and cancer chemopreventive activity

被引:22
|
作者
Muccio, DD
Brouillette, WJ
Alam, M
Vaezi, MF
Sani, BP
Venepally, P
Reddy, L
Li, E
Norris, AW
SimpsonHerren, L
Hill, DL
机构
[1] SO RES INST,BIRMINGHAM,AL 35205
[2] WASHINGTON UNIV,DEPT MED,ST LOUIS,MO 63110
[3] WASHINGTON UNIV,DEPT BIOCHEM & MOL BIOPHYS,ST LOUIS,MO 63110
关键词
D O I
10.1021/jm9603126
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
We recently demonstrated that conformationally defined 6-s-trans-retinoic acid (RA) analogs were effective in the prevention of skin papillomas (Vaezi et al. J. Med. Chem. 1994, 37, 4499-4507) and selective agonists for nuclear receptor binding and activation (Alam et al. J. Med. Chem. 1995, 38, 2302-2310). In order to probe important structure-activity relationships, we evaluated a homologous series of four 6-s-trans-retinoids that are 8-(2'-cyclohexen-1'-ylidene)-3,7-dimethyl-2,4,6-octatrienoic acids with different substituents at 2' (R(2)) and 3' (R(1)) positions on the cyclohexene ring. UAB1 (R(1) = R(2) = H), UAB4 (R(1) = R(2) = Me), UAB7 (R(1) = Me, R(2) = iPr), and UAB8 (R(1) = Et, R(2) = iPr) contain alkyl R groups that mimic, to different extents, portions of the trimethylcyclohexenyl ring of RA. Both 9Z- and all-E-isomers of these retinoids were evaluated in binding assays for cellular retinoic acid-binding proteins (CRABP-I and CRABP-II), a nuclear retinoic acid receptor (RAR alpha), and a nuclear retinoid X receptor (RXR alpha). The all E-isomers of UAB retinoids bound tightly to CRABPs and RAR alpha, the binding affinity of the all-E-isomer increased systematically from UAB1 to UAB8, and binding for the latter was comparable to that of all-E-RA. In contrast to RA, the (9Z)-UAB retinoids were at least 200-fold less active than the all-E-isomers in binding to RAR alpha. The (9Z)-UAB isomers exhibited increasingly stronger binding to RXR alpha, and (9Z)-UAB8 was nearly as effective as (9Z)-RA in binding affinity. The retinoids were also evaluated in gene expression assays mediated by RAR alpha and RXR alpha homodimers or RAR alpha/RXR alpha heterodimers. Consistent with the binding affinities, the (all-E)-UAB retinoids activated gene transciption mediated by RAR alpha homodimers or RAR alpha/RXR alpha heterodimers, while the (9Z)-UAB isomers activated only the RXR alpha homodimer-mediated transcription. The all-E- and 9Z-isomers of the UAB retinoids were further evaluated for their capacity to prevent the induction of mouse skin papillomas. When compared to RA, only the (all-E)-UAB retinoids containing bulky R(1) and R(2) groups were effective in this chemoprevention assay. (9Z)-RA displayed equal capacity as RA to prevent papillomas, while the 9Z-isomers of the UAB retinoids were much less effective. Taken together, these studies demonstrate that the cyclohexenyl ring substituents of 6-s-trans-UAB retinoids are important for their biological activities and that the chemopreventive effect of the all-E-isomers of these retinoids correlates well with their capacity to bind to RARs and activate RAR/RXR-mediated transcription.
引用
收藏
页码:3625 / 3635
页数:11
相关论文
共 50 条
  • [1] CONFORMATIONALLY DEFINED 6-S-TRANS-RETINOIC ACID ANALOGS .2. SELECTIVE AGONISTS FOR NUCLEAR RECEPTOR-BINDING AND TRANSCRIPTIONAL ACTIVITY
    ALAM, M
    ZHESTKOV, V
    SANI, BP
    VENEPALLY, P
    LEVIN, AA
    KAZMER, S
    LI, E
    NORRIS, AW
    ZHANG, XK
    LEE, MO
    HILL, DL
    LIN, TH
    BROUILLETTE, WJ
    MUCCIO, DD
    JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (13) : 2302 - 2310
  • [2] A CONFORMATIONALLY DEFINED 6-S-TRANS-RETINOIC ACID ISOMER - SYNTHESIS, CHEMOPREVENTIVE ACTIVITY, AND TOXICITY
    VAEZI, MF
    ALAM, M
    SANI, BP
    ROGERS, TS
    SIMPSONHERREN, L
    WILLE, JJ
    HILL, DL
    DORAN, TI
    BROUILLETTE, WJ
    MUCCIO, DD
    JOURNAL OF MEDICINAL CHEMISTRY, 1994, 37 (26) : 4499 - 4507
  • [3] Conformationally defined retinoic acid analogs: Synthesis and structure-activity relationships for ring-substituted analogs of 9cUAB30.
    Deshpande, AM
    Atigadda, VR
    Vines, KK
    Xia, M
    Zhang, XK
    Muccio, DD
    Brouillette, WJ
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 229 : U140 - U141
  • [4] Synthesis and structure-activity relationships of retinoid X receptor selective diaryl sulfide analogs of retinoic acid
    Beard, RL
    Colon, DF
    Song, TK
    Davies, PJA
    Kochhar, DM
    Chandraratna, RAS
    JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (18) : 3556 - 3563
  • [5] Synthesis and mammary cancer chemopreventive activity of a new conformationally defined retinoic acid analog, UAB76.
    Atigadda, VR
    Brouillette, WJ
    Grubbs, CJ
    Muccio, DD
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 226 : U43 - U43
  • [6] STRUCTURE-ACTIVITY RELATIONSHIPS IN DNA BINDING AND NUCLEAR EFFECTS OF AFLATOXIN AND ANALOGS .2.
    EDWARDS, GS
    WOGAN, GN
    SPORN, MB
    PONG, RS
    CANCER RESEARCH, 1971, 31 (12) : 1943 - &
  • [7] Syntheses and structure-activity relationships of novel retinoic acid receptor alpha agonists.
    Nagal, M
    Yoshimura, H
    Kikuchi, K
    Hibi, S
    Tagami, K
    Satoh, T
    Tokuhara, N
    Tai, K
    Hida, T
    Yamauchi, T
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1999, 217 : U1170 - U1170
  • [8] Synthesis and structure-activity relationships of conformationally constrained histamine H3 receptor agonists
    Kitbunnadaj, R
    Zuiderveld, OP
    De Esch, IJP
    Vollinga, RC
    Bakker, R
    Lutz, M
    Spek, AL
    Cavoy, E
    Deltent, MF
    Menge, WMPB
    Timmerman, H
    Leurs, R
    JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (25) : 5445 - 5457
  • [9] CHEMICAL STRUCTURE AND TERATOGENIC PROPERTIES .3. REVIEW OF AVAILABLE DATA ON STRUCTURE-ACTIVITY RELATIONSHIPS AND MECHANISM OF ACTION OF THALIDOMIDE ANALOGS
    JONSSON, NA
    ACTA PHARMACEUTICA SUECICA, 1972, 9 (06): : 521 - 542
  • [10] Structure-activity relationships for nicotine analogs comparing competition for [3H]nicotine binding and psychotropic potency
    Wang, DX
    Booth, H
    Lerner-Marmarosh, N
    Osdene, TS
    Abood, LG
    DRUG DEVELOPMENT RESEARCH, 1998, 45 (01) : 10 - 16